No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Red One Medical and Prytime Medical Devices Announce Exclusive Partnership

Editor: What To Know

  • As a Service Disabled Veteran Owned Small Business (SDVOSB), Red One Medical specializes in serving the US military’s needs in Operational Medicine, Military Treatment Facilities and the VA.
  • Prytime Medical’s newly refined flagship product, the ER-REBOA™ PLUS Catheter, provides clinicians  an effective tool to control bleeding and stabilize patients in hemorrhagic shock, utilizing a minimally invasive technique called REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta).
  • Red One Medical, a proven government contractor providing best-in-class medical supplies to Veterans Affairs and the Department of Defense, is proud to exclusively partner with Prytime Medical Devices, Inc.

Red One Medical, a proven government contractor providing best-in-class medical supplies to Veterans Affairs and the Department of Defense, is proud to exclusively partner with Prytime Medical Devices, Inc. (The REBOA Company™), a privately held medical technology company focused on minimally invasive solutions for trauma.

As a Service Disabled Veteran Owned Small Business (SDVOSB), Red One Medical specializes in serving the US military’s needs in Operational Medicine, Military Treatment Facilities and the VA.

Prytime Medical’s newly refined flagship product, the ER-REBOA™ PLUS Catheter, provides clinicians  an effective tool to control bleeding and stabilize patients in hemorrhagic shock, utilizing a minimally invasive technique called REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta). The catheter was designed specifically for emergency and critical care environments, making it a perfect match for combat medicine.

“Our flagship technology and technique arose from military medicine in the field, and now we’re bringing the lessons learned from war to civilian trauma back home,” said Prytime Medical’s CEO David Spencer. “Our partnership with veteran-owned Red One Medical supports our original mission to support combat wounded military members and those who treat them.”

“We’re proud to get these cutting-edge medical devices into the hands of US military trauma surgeons and other medical providers close to the point of injury,” said Red One Medical’s CEO Charles Pollak. “Red One works hard to bridge the gap between private sector innovations and government contracting, because we know these devices can save lives.”

The new PLUS design improves on the original ER-REBOA™ by adding five new features to help control massive non-compressible hemorrhage, including:
1) “Landing zone” markers to easily identify zones 1 and 3
2) Repackaged peel away sheath  to reduce prep time
3) Length markers on both sides of catheter for better visibility
4) Documentation tag to capture critical information
5) Guidewire compatible  for subsequent vascular procedures

Prytime Medical also offers the ER-REBOA™ PLUS Training Catheter and ARTI Simulator for arterial access training.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy